TOFIDENCE

Swiss trademark · 796748 · Word mark · In force

Register entry

Registration number
796748
Application number
01465/2023
Status
In force
Type
Word mark
Filed
Feb 3, 2023
Registered
May 3, 2023
Published
May 3, 2023
Protected until
Feb 3, 2033
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von Arthritis; monoklonale Antikörper gegen den Interleukin-6 (IL-6)-Rezeptor zur Behandlung von Krankheiten, die durch die IL-6-Produktion verursacht werden; pharmazeutische Präparate zur Behandlung des Zytokin-Freisetzungssyndroms; pharmazeutische Präparate für die systemischen Sklerose-assoziierte interstitielle Lungenerkrankung; pharmazeutische Präparate.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 22, 2024

    Transferred

    Owner
    Biogen MA Inc., 225 Binney Street, Cambridge, MA 02142, USA → Biogen International GmbH, Neuhofstrasse 30, 6340 Baar

    Published in Swissreg on 22.05.2024

  2. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  3. May 3, 2023

    Registered

    Published in Swissreg on 03.05.2023

Parties

Holder

Biogen International GmbH

Neuhofstrasse 30, 6340 Baar

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.